Novo Nordisk successfully kicks off final-stage trials for first diabetes pill

COPENHAGEN, Feb 22 (Reuters) - The world's largest diabetes drugmaker Novo Nordisk on Thursday presented the first successful data from a final-stage study for a pill it hopes will transform the diabetes market.